Mediloq

Mediloq

Early Stage

Sustainable Child-Safe Packaging

Sustainable Child-Safe Packaging

Overview

Raised to Date: Raised: $20,271

Total Commitments ($USD)

Platform

StartEngine

Start Date

12/04/2022

Close Date

02/03/2023

Min. Goal
$15,000
Max. Goal
$581,202
Min. Investment

$249

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$2.37

Pre-Money Valuation

$5,994,754

Rolling Commitments ($USD)

Status
Funded
Reporting Date

02/27/2023

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$338

# of Investors

17

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2016

Industry

Consumer Products, Goods & Services

Tech Sector

Non-Tech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

Low

Location

Boulder, Colorado

Business Type

Growth

Mediloq, with a valuation of $5.99 million, is raising funds on StartEngine. The company makes and sells closed-loop child-safe containers for pharmaceutical and supplement manufacturers. The containers of Mediloq are safe and sustainable alternatives to disposable plastic packaging and are durable enough to remain child-safe over a lifetime of reuses and refills. Mediloq has generated significant e-commerce revenue and has signed an agreement with a company to sell its products into over 2,000 B&M stores across the US. Dan Estoque, Nicolas Legare, and Henry Burgess-Marshall founded Mediloq in October 2016. The current crowdfunding campaign has a minimum target of $14,999.73 and a maximum target of $581,202. The campaign proceeds will be used to develop next-gen sustainable child-safe packaging, automated wash and test equipment, and a kiosk collection system, develop partnerships, build a distribution network, and strengthen the patent positions.

Summary Profit and Loss Statement

FY 2021 FY 2020

Revenue

$23,733

$39,091

COGS

$6,906

$52,211

Tax

$0

$0

 

 

Net Income

$-22,875

$-45,784

Summary Balance Sheet

FY 2021 FY 2020

Cash

$791

$2,981

Accounts Receivable

$0

$0

Total Assets

$791

$55,363

Short-Term Debt

$81,190

$58,724

Long-Term Debt

$0

$126,615

Total Liabilities

$81,190

$185,339

Financials as of: 12/04/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Mediloq 02/02/2023 StartEngine $5,994,754 $20,271 Equity - Common Funded RegCF
Mediloq 09/28/2022 Ignite Social Impact $3,125,000 $36,800 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Mediloq on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $5,994,754
Price per Share: $2.37

Follow company

Follow Mediloq on StartEngine 2022

Buy Mediloq's Deal Report

Warning: according to the close date for this deal, Mediloq may no longer be accepting investments.

Mediloq Deal Report

Get KingsCrowd’s comprehensive report on Mediloq including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Mediloq is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Mediloq deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge